Migraine and Neuropathic Pain in Osteoarthritis
MEDUSA
Prevalence of Migraine and Neuropathic Pain in Osteoarthritis: Multicenter, Multidisciplinary, Cross-sectional Epidemiological Study.
MEDUSA
Prevalence of Migraine and Neuropathic Pain in Osteoarthritis: Multicenter, Multidisciplinary, Cross-sectional Epidemiological Study.
Sponsor study identifier
Secondary identifiers
OTHER · ANSM
observational
1,000
1 country
1
Study Start
March 27, 2024
Actual (reported)Primary Completion
March 27, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
March 27, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The goal of this observational study is to estimate the frequency of neuropathic pain and migraines in a group of patients with osteoarthritis of the knees, hips, hands, spine or other joints. In addition to their usual care for osteoarthritis, participants will complete questionnaires to define migraine and neuropathic pain.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 27, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 8, 2024
Actual (reported)January 25, 2024
Actual (reported)March 27, 2024
Actual (reported)March 27, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
March 27, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
the presence of neuropathic pain in patients
Neuropathic pain is defined by a "Douleur Neuropathique" (DN)-4 questionnaire given to the patients, A patient is considered to have characteristics of neuropathic pain if their DN-4 questionnaire score is greater than 4. DN-4 is a questionnaire used to estimate the likelihood of neuropathic pain in patients and to aid in the diagnosis of neuropathic pain. There are 4 items with a total of 10 questions, the patient must answer yes or no to each question and the doctor counts the answers at the end of the questionnaire, 1 for a yes answer and 0 for a no answer, and the sum obtained is the patient's score.
10 minutes
the presence of migraine in patients
Completing the headache questionnaire of the International Headache Society (IHS). Strict migraine is defined as meeting all the criteria for migraine as defined by the IHS. Probable migraine sufferers are those who meet all but one of the migraine criteria. IHS criteria is defined by : A. At least five seizures meeting criteria B through D. B. Headache attacks lasting 4 to 72 hours (without treatment). C. Headache with at least two of the following features : One-sided; pulsating; moderate or severe; worsened by routine physical activities, such as climbing or descending stairs D. At least one of the following during the headache :nausea and/or vomiting; photophobia and phonophobia. E. Clinical examination should be normal between attacks. In case of doubt, an organic disorder must be excluded by appropriate additional investigations.
10 minutes
the presence of anxiety and depression symptoms in patients
10 minutes
measure the level of catastrophizing thoughts related to pain in patients
10 minutes
Impact of headhache in patients
10 minutes
Patients diagnosed with articular and/or spinal osteoarthritis, under the care of the University Hospital of Clermont-Ferrand (Rheumatology, Physical Medicine and Rehabilitation, Sports Medicine, Occupational Health and Environment, Orthopedics), and/or managed by specialized professionals (general practitioners, sports physicians, rheumatologists, rehabilitation specialists, orthopedic surgeons) in private medical practice
CHU Clermont-Ferrand
Clermont-Ferrand, France, France
Sylvain MATHIEU
University Hospital, Clermont-Ferrand
First Submitted
January 8, 2024
First Posted
January 25, 2024
Study Start
March 27, 2024
Actual (reported)Primary Completion
March 27, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Paracetamol and Neuropathic Pain
Contact the study team to confirm eligibility.
Study Completion
March 27, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
March 10, 2025
Record last verified: 2025-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: